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Background: Bioactivities of Docosahexaenoic acid (DHA) and Eicosapentaenoic acid (EPA) depend on their
chemical forms. The present study was to investigate short term effects of triglyceride (TG), ethyl ester (EE), free
fatty acid (FFA) and phospholipid (PL) forms of omega-3 fatty acid (FA) on lipid metabolism in mice, fed high fat or
low fat diet.
Method: Male Balb/c mice were fed with 0.7% different Omega-3 fatty acid formulation: DHA bound free fatty acid
(DHA-FFA), DHA bound triglyceride (DHA-TG), DHA bound ethyl ester (DHA-EE) and DHA bound phospholipid
(DHA-PL) for 1 week, with dietary fat levels at 5% and 22.5%. Serum and hepatic lipid concentrations were analyzed,
as well as the fatty acid composition of liver and brain.
Result: At low fat level, serum total cholesterol (TC) level in mice fed diets with DHA-FFA, DHA-EE and DHA-PL
were significantly lower than that in the control group (P< 0.05). Hepatic TG level decreased significantly in mice
fed diets with DHA-TG (P< 0.05), DHA-EE (P< 0.05) and DHA-PL (P< 0.05), while TC level in liver was significantly
lower in mice fed diets with TG and EE compared with the control group (P< 0.05). At high fat level, mice fed diets
with DHA-EE and DHA-PL had significantly lower hepatic TC level compared with the control diet (P< 0.05).
Hepatic PL concentration experienced a significant increase in mice fed the diet with PL at high fat level (P< 0.05).
Furthermore, both at low and high fat levels, hepatic DHA level significantly increased and AA level significantly
decreased in all forms of DHA groups (P< 0.05), compared to control groups at two different fat levels, respectively.
Additionally, cerebral DHA level in mice fed diets with DHA-FFA, DHA-EE and DHA-PL significantly increased
compared with the control at high fat level (P< 0.05), but no significant differences were observed among dietary
treatments for mice fed diets with low fat level.
Conclusion: The present study suggested that not only total dietary fat content but also the molecular forms of
omega-3 fatty acids contributed to lipid metabolism in mice. DHA-PL showed effective bioactivity in decreasing
hepatic and serum TC, TG levels and increasing omega-3 concentration in liver and brain.
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Omega-3 polyunsaturated fatty acids such as DHA and
EPA contained in fish oil have long been suggested ef-
fective bioactive substances [1]. They have been pro-
posed outstanding antithrombotic effects and efficient in
prevention of cardiovascular diseases [2,3] through
modulation of blood lipids [4] and lipoproteins [5]. The
ingestion of long chain omega-3 polyunsaturated fatty
acid (n-3 LC-PUFA) can also prevent or treat nonalco-
holic fatty liver disease (NAFLD) [6-8]. Furthermore,
omega-3 PUFA especially DHA have been recognized as
key substances in signal transduction and as reservoirs
of lipid messengers [4,9]. Based on the biological func-
tions above, an increased intake of DHA and EPA has
been recommended [10-12].
DHA and EPA in natural fish oil exist as triglycerides
(TG) and phospholipids (PL), while they can also be
ingested in the form of purified ethyl esters (EE) or free
fatty acids (FFA) [13]. EE is the most common form in
fish oil products, since it is convenient to concentrate
highly-purified EE bound omega-3 PUFA. However, this
formulation may lead to ethanol toxicity. TG bound
omega-3 is a natural form of fish oil and is easily
absorbed though purification may be a major problem.
Effects of TG, EE and FFA forms of fish oil on lipid me-
tabolism in mammals have been compared and
remained to be controversial. Dyerberg reported that the
bioavailability of FFA was not significantly different from
natural triglycerides, whereas the bioavailability of EE
was inferior to TG [14]. Most of other relevant research
confirmed that TG is superior to EE [15-18]. However,
Krokan suggested that bioavailability of EPA and DHA is
as efficient in ethyl esters as in glyceryl esters [19]. Diet-
ary phospholipids have been suggested biological and
nutritional functions. As essential constituents of cell
membrane, phospholipids, such as phosphatidylcholine
(PC) and phosphatidylethanolamine (PE), are remarkable
surface active agents and also believed to be good bio-
active substances in resisting hypertriglyceridemia [20].
Recent research has suggested superior functions of
PL bound DHA, including anti-inflammation [21], anti-
oxidation [22], promoting the differentiation of erythro-
leukemia cancer cells [23,24] and antitumor functions
[25]. Until recently few studies have focused on the
comparison of effects between PL bound omega-3 and
other formulations. Thus, the lack of a controlled study
comparing those four particular forms of omega-3 fatty
acid(TG, EE, FFA, PL) make it necessary to investigate
the effects of different omega-3 fatty acid formulation on
lipid metabolism in mice.
Researchers have suggested that not only chemical
form but co-ingested fat level can contribute to bioavail-
ability of omega-3 fish oil. Lawson and Hughes have
reported that bioavailability of omega-3 s administeredas standard ethyl ester form increased three-folds when
ingested in a high fat meal, whereas triglycerides remain
more stable in diets with different fat level [26].
Recently, Tanaka et al. [27] has reported the effect of
long-term feeding and relatively high dosage of TG, EE,
FFA and PL forms omega-3 PUFA on lipid absorption in
mice. Up to date, however, the comprehensive effect of
short-term, low dosage feeding of different omega-3 s for-
mulations on lipid metabolism in mice, with different levels
of fat context, hasn’t been reported. In the present study,
we prepared TG, EE, FFA, PL forms of DHA and EPA and
compared the effects of short term (1 week), low dosage
(0.7%) of those four omega-3 formulations on lipid metab-
olism in mice. Additionally, the influence of different co-
ingested fat level on lipid metabolism was also analyzed.
Materials and methods
Preparation of different forms of EPA and DHA
In the present study, four different forms of omega-3
PUFAs were prepared, including TG, EE, FFA and PL
forms. Dietary DHA-PL was extracted from squid roe by
the method of Folch [28], and purified by the silica gel
chromatography. The proportion of PC and PE in dietary
PL were 93.3% and 3.88%, respectively, with 2.82% for the
remaining constituent, according to HPLC-ELSD analysis.
The ratio of DHA to EPA in dietary PL was 2.6:1, deter-
mined by an Agilent 6890 Gas chromatography. To make
2.6:1 a standard for the ratio of DHA to EPA in each
DHA supplement, two lipid products- a fish oil product
(DHA%: 6.5%, EPA%: 22%) provided by Wanlian Pharma-
ceutical Inc., and Algamac microalgae powder (DHA%:
33.5%, EPA%: 0%) from Xiamen Huison Biotech Co., Ltd-
were mixed as 1:1.5 to make dietary DHA-TG. DHA-FFA
was a mixture of two oil products (X: DHA%: 65%, EPA%:
11%; Y: DHA%: 33%, EPA%: 25%) as X:Y= 1:1.14, pur-
chased from Haiyuan Health Biological Science and Tech-
nology Co., Ltd (Hebei, China). TG bound omega-3 s
(DHA-EE) was prepared by the method of esterification
according to Li DW et al. [29], using DHA-FFA as sub-
strate. The ratio of DHA to EPA in all prepared diets was
approximately 2.6:1. The concentration of omega-3 PUFA
for each omega-3 formulation was 8.5% for EPA and
22.4% for DHA in TG, 20.2% for EPA and 58.6% for DHA
in EE, 20.3% for EPA and 56.6% for DHA in FFA, 8.9% for
EPA and 23.3% for DHA in PL.
Animals and diets
Male Balb/c mice (20 ± 2) were provided by Vital River
Laboratories (Beijing, China),and randomly assigned to
ten groups: Control group, TG group, FFA group, EE
group and PL group in both low fat (LF) and high fat
(HF) diet, with 6 mice in each group. The mice were
housed individually in metal cages under a 12 h light/
dark cycle, a constant temperature of 24 ± 1 °C, and a
Table 1 Formulation of the experimental diets (% dry matter)
Ingredient LF-Control LF-TG LF-FFA LF-PL LF-EE HF-Control HF-TG HF-FFA HF-PL HF-EE
Fish oil 0 23.75 9.05 30.35 9.51 0 23.75 9.05 30.35 9.51
Soybean oil 20 13.10 5.50 13.60 5.60 50 44.72 47.99 44.92 47.89
Lard oil 30 13.10 34.40 13.60 35.40 175 156.53 167.96 157.24 167.60
Cornstarch 150 150 150 150 150 75 75 75 75 75
Sucrose 500 500 500 500 500 400 400 400 400 400
Casein 200 200 200 200 200 200 200 200 200 200
Fiber 50 50 50 50 50 50 50 50 50 50
Mineral 35 35 35 35 35 35 35 35 35 35
Vitamin 10 10 10 10 10 10 10 10 10 10
Choline bitartrate 2 2 2 2 2 2 2 2 2 2
DL-meth 3 3 3 3 3 3 3 3 3 3
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and food for 7 days.
The basal diets were modified basing on AIN76, as
shown in Table 1. To make omega-3 PUFA concentration
equal in all the omega-3 diets, the supplement of fish oil
in each group was adjusted basing on the omega-3 con-
centration in the different fish oil formulation prepared
and the molar mass of PL, TG, EE or FFA. All omega-3
supplement groups contained 0.7% DHA+EPA, and the
ratio of DHA/EPA is approximately 2.6 (Table 2).
Blood samples were collected by cardiac puncture after
12-hour fast. Livers, brains, kidneys, hearts, perirenal
white adipose tissues and epididymal adipose tissuesTable 2 Fatty acid composition of the experimental diets (g/k
Fatty acid LF-Control LF-TG LF-FFA LF-EE LF-
C14:0 0.45 1.68 0.51 0.53 0.70
C15:0 - - - - 0.22
C16:0 9.14 13.21 8.48 8.72 11.3
C16:1 0.67 1.45 0.77 0.79 1.17
C17:0 - 0.59 - - -
C18:0 3.84 2.33 3.88 3.98 4.26
C18:1 17.08 9.73 16.35 16.76 9.77
C18:2 15.20 8.94 8.32 8.51 9.28
C18:3 1.42 0.93 0.39 0.40 0.97
C18:4 - 0.45 - - -
C20:1 - - 0.23 0.21 2.19
C20:2 - 0.46 0.19 0.15 -
C20:4 - - 0.25 0.24 0.55
C20:5 - 1.94 1.86 1.76 1.95
C22:1 - - 0.36 0.31 -
C22:2 - - 0.19 0.18 -
C22:4 - 0.94 0.26 0.26 0.33
C22:6 - 5.13 5.13 5.13 5.13
Total FA 47.80 47.76 47.18 47.93 47.8were excised and weighed immediately. Serum was
extracted from blood sample by centrifuging the blood
at 7500 × g for 15 min. All data were conducted accord-
ing to the guidelines provided by the ethical committee
of experimental animal care at Ocean University of
China (Qingdao, China).
Serum and hepatic lipids determination
The concentrations of serum TG and TC were determined
with enzymatic reagent kits (Biosino, Beijing, China). Liver
lipids were extracted with chloroform-methanol 2:1 as
described by Folch et al. [28], and then dissolved with Tri-
ton X-100. The concentrations of hepatic TG and TC wasg)
PL HF-Control HF-TG HF-FFA HF-EE HF-PL
2.62 3.82 2.51 2.51 2.85
- - - - 0.22
5 45.54 49.45 43.75 43.65 47.60
3.92 4.66 3.76 3.75 4.39
- 0.59 - - -
20.09 18.47 19.36 19.31 20.41
85.87 78.17 82.78 82.57 78.25
53.49 47.84 51.43 51.30 48.06
3.55 3.17 3.41 3.40 3.19
- 0.45 - - -
- - 0.23 0.21 2.19
- 0.46 0.19 0.15 -
- - 0.25 0.24 0.55
- 1.94 1.86 1.76 1.95
- - 0.36 0.31 -
- - 0.19 0.18 -
- 0.94 0.26 0.26 0.33
- 5.13 5.13 5.13 5.13
7 215.07 215.09 215.47 214.72 215.10
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China), and total phospholipids levels in liver were ana-
lyzed by the methods of Bartlett [30].
Analysis of fatty acid composition
Lipids extracted from livers and brains were prepared by
transmethylation with HCL/methanol and the fatty acid
composition was analyzed with gas chromatograph.
An Agilent 6890 gas chromatograph, equipped with a
flame-ionization detector, was used to analyze the com-
position of cerebral and hepatic fatty acid and also FA
composition of diet in each group. The column was a HP-
INNOWAX capillary column (30 m×0.32 mm×0.25 μm).
The temperature of the detector and injector were kept
constant at 250°C and 240°C, respectively, and the oven
temperature was increased from 170°C to 240°C at 3°C/
min and held at 240°C for 15 min. Nitrogen was used as
carrier gas at the flow rate of 1.2 mL/min.
Statistical analysis
The results are presented as mean ± standard deviations.
All data were subjected to analysis of variance using the
SPSS software (version 18.0; SPSS Inc., Chicago, IL,
USA). Differences between the means were tested by
one-way ANOVA, and all detected significant differences
were further evaluated by Duncan multiple. The level of
significance chosen was P< 0.05.
Results
General observation
After 7 days observation, there was no significant differ-
ence in daily food intake among 10 dietary treatments (P
> 0.05). In low fat diet, body weight gain was significantly
lower (P< 0.05) in LF-EE group (P< 0.05) and LF-PL
group (P< 0.05), but not in LF-TG or LF-FFA group, com-









LF-Control 1.58 ± 0.19a 5.09 ± 0.16a 1.69 ± 0.05a 0.4
LF-TG 1.32 ± 0.11ab 5.10 ± 0.04a 1.64 ± 0.02a 0.5
LF-FFA 1.20 ± 0.17abc 5.27 ± 0.16a 1.67 ± 0.03a 0.5
LF-EE 0.70 ± 0.28bc 4.98 ± 0.07a 1.72 ± 0.05a 0.5
LF-PL 0.50 ± 0.35c 4.99 ± 0.18a 1.67 ± 0.08a 0.4
HF-Control 2.28 ± 0.24d 4.90 ± 0.14de 1.71 ± 0.03d 0.5
HF-TG 2.22 ± 0.27d 4.60 ± 0.07de 1.71 ± 0.04d 0.5
HF-FFA 2.27 ± 0.10d 4.84 ± 0.06de 1.67 ± 0.06d 0.5
HF-EE 2.18 ± 0.13d 4.95 ± 0.17d 1.68 ± 0.04d 0.5
HF-PL 2.28 ± 0.20d 4.58 ± 0.06e 1.72 ± 0.03d 0.5
WAT: Weight of adipose tissue BW: Body weight
a–c At low fat level, means in one column sharing the same superscript letter are n
d–f At high fat level, means in one column sharing the same superscript letter are ntissue of mice in LF-TG and LF-FFA was significantly
lower (P< 0.05), compared to LF control group (P< 0.05).
Body weight gain of mice in DHA-EE group was also sig-
nificantly restrained (P< 0.05), and weight of perirenal adi-
pose tissue in this group declined significantly (P< 0.05).
In high fat diet, heart weight of mice in PL group and
weight of epididymal adipose tissue of FFA and EE group
both increased significantly(P< 0.05), while no changes
were examined in body weight of any group according
to values of P< 0.05. (Table 3)
Serum lipids concentration
After one-week feeding, serum TC concentration in
mice fed the diet with DHA-FFA, DHA-EE and DHA-
PL at low fat level were significantly lower than that in
the control group (P< 0.05), while for high fat level, no
such difference was observed. Furthermore, there was
no significant difference in serum TG concentration
among dietary treatments with different forms of DHA
ingestion at either low fat or high fat level. (Table 4)
Hepatic lipids concentrations
In short-term feeding of omega-3 s, hepatic TG level
decreased significantly in DHA-TG (P< 0.05), DHA-EE
(P< 0.05) and DHA-PL (P< 0.05) groups, while hepatic
TC level decreased significantly in DHA-TG and DHA-
EE groups (P< 0.05), in low fat diets. While in high fat
groups, hepatic TC level decreased significantly in DHA-
EE and DHA-PL group in high fat context(P< 0.05).
Hepatic PL level experienced a significant increase in PL
group in high fat diet (P< 0.05). (Table 5)
Fatty acid composition of liver
Hepatic fatty acid composition, especially the level of
DHA and AA, changed drastically after one-week feeding









9 ± 0.02a 1.45 ± 0.04a 0.43 ± 0.13ab 1.46 ± 0.13ab
2 ± 0.01a 1.46 ± 0.03a 0.66 ± 0.07a 1.64 ± 0.06a
0 ± 0.01a 1.44 ± 0.05a 0.54 ± 0.04a 1.36 ± 0.08abc
0 ± 0.01a 1.46 ± 0.05a 0.17 ± 0.09b 1.23 ± 0.12bc
9 ± 0.01a 1.46 ± 0.02a 0.24 ± 0.10b 1.00 ± 0.20c
1 ± 0.01d 1.44 ± 0.05d 0.30 ± 0.11d 1.19 ± 0.10de
1 ± 0.01d 1.53 ± 0.05d 0.16 ± 0.10d 1.00 ± 0.20d
3 ± 0.02de 1.43 ± 0.02d 0.30 ± 0.09d 1.59 ± 0.16f
2 ± 0.03d 1.45 ± 0.05d 0.29 ± 0.07d 1.69 ± 0.08f
8 ± 0.03e 1.48 ± 0.04d 0.23 ± 0.05d 1.45 ± 0.05ef
ot significantly different determined by Duncan Multiple (P> 0.05)
ot significantly different determined by Duncan Multiple (P> 0.05)
Table 4 Effects of different forms of n-3 FA on serum
lipids concentration
Group TG TC
LF Control 180± 20ab 210 ± 8a
LF-TG 215± 15a 194 ± 4ab
LF-FFA 213± 9a 173 ± 4bc
LF-EE 139± 19b 126 ± 12d
LF-PL 150± 18b 145 ± 9cd
HF Control 137± 18ef 157 ± 17e
HF-TG 138± 22ef 145 ± 10e
HF-FFA 189± 21e 175 ± 11e
HF-EE 129± 15f 172 ± 15e
HF-PL 159± 13bf 161 ± 9e
a–d At low fat level, means in one column sharing the same superscript letter
are not significantly different determined by Duncan Multiple (P> 0.05)
e–f At high fat level, means in one column sharing the same superscript letter
are not significantly different determined by Duncan Multiple (P> 0.05)
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DHA-EE and DHA-PL were significantly increased by
49.4%, 32.9%, 38.8% and 61.2% (P< 0.05) respectively
compared with the LF-control group. For mice fed diets
with high fat level, hepatic DHA level in mice fed diets
with DHA-TG, DHA-FFA, DHA-EE and DHA-PL were
also significantly increased by 50.6%, 44.3%, 36.7%, 53.1%
(P< 0.05) separately compared to the HF-control. How-
ever, at both fat level, AA level was significantly decreased
in all forms of DHA groups (P< 0.05). (Table 6)
Fatty acid composition of brain
Cerebral DHA level of DHA-FFA, DHA-EE and DHA-
PL groups experienced a significant increase in high fat
diets (P< 0.05), by 9.1%, 9.1% and 11.0% respectively,Table 5 Effects of different forms of n-3 FA on hepatic
lipids concentration
Group TG TC PL
LF Control 47.6 ± 10.2a 2.74 ± 0.22a 33.0 ± 1.3a
LF-TG 26.3 ± 2.8b 2.22 ± 0.13b 29.5 ± 1.5a
LF-FFA 31.3 ± 3.0ab 2.52 ± 0.07ab 31.2 ± 0.9a
LF-EE 16.9 ± 4.1b 2.17 ± 0.23b 31.9 ± 1.7a
LF-PL 22.3 ± 5.7b 2.58 ± 0.08ab 33.2 ± 0.7a
HF Control 38.0 ± 2.1c 2.55 ± 0.12c 30.6 ± 0.4c
HF-TG 36.2 ± 4.8c 2.45 ± 0.16cd 32.9 ± 1.3cd
HF-FFA 46.5 ± 7.8c 2.56 ± 0.13c 32.3 ± 0.7cd
HF-EE 35.3 ± 7.3c 1.97 ± 0.28d 33.3 ± 1.5cd
HF-PL 34.3 ± 2.5c 1.97 ± 0.11d 34.5 ± 0.8d
a–b At low fat level, means in one column sharing the same superscript letter
are not significantly different determined by Duncan Multiple (P> 0.05)
c–d At low fat level, means in one column sharing the same superscript letter
are not significantly different determined by Duncan Multiple (P> 0.05)compared with the high fat control group. There was no
significant change of cerebral DHA level in HF-TG
group, but with an increase of 5.5% compared with HF-
control group. No significant changes of DHA level were
observed for low fat diets. (Table 7)
Discussion
In order to compare the effects of TG, EE, FFA and PL
forms of omega-3 s on lipid metabolism in mice, the
ratio of DHA to EPA and their respective amount in
diets were confirmed to be statistically equal in each
DHA supplement group. Furthermore, fat level in diets
was considered, for previous study has suggested that fat
level in diets can significantly affect bioavailability of
omega-3 fish oil [26].
Following 1 week feeding of omega-3 s, serum TC and
TG levels in mice fed diets with DHA-PL, DHA-FFA
and DHA-EE were significantly decreased at low fat
compared to LF control, while no significant difference
were observed among high fat fed mice (Table 4). The
result suggested that PL, FFA and EE forms of omega-
3 s were effective in inhibiting serum lipids concentra-
tion compared with TG. Additionally, the results implied
that high fat content in diets may restrain the thera-
peutic effect of omega-3 s on hyper-triglyceridemia com-
pared with low fat content. This result was different
from Lawson et al., who reported that high fat content
could increase the bioavailability of DHA, other than
low fat content [26]. The difference implied that high fat
content was effective in increasing the bioavailability of
DHA but not the efficiency of DHA in lowering TC and
TG concentrations in serum. The inefficiency of omega-
3 supplement in high fat fed mice was probably based
on its lower ratio in the total fat content, for the ratio of
DHA+EPA in diet was 0.7% in both high fat and low fat
groups, while the ratio of total fat content in diet
increased a lot in high fat groups.
At low fat level, the decrease of TC and TG level in
liver mainly existed in PL, TG and EE groups, and no
significant difference was observed between TG and EE.
Especially, hepatic PL concentration experienced a sig-
nificant increase in PL group for high fat diet. These
results suggested better effect of PL, TG and EE bound
DHA in decreasing hepatic TC, TG levels compared
with FFA, and equal efficiency of EE and TG in decreas-
ing TC and TG level in liver. This was different from the
previous study [31], in which DHA-TG reduced liver TG
level more effectively than DHA-EE after one-week feed-
ing. The indifference between EE and TG forms in the
present study was probably due to the lower dosage of
DHA+EPA (0.7%) supplement. PL bound DHA is effi-
cient in increasing PL level in liver. This could probably
account for the increase of hepatic DHA level, because
DHA-PL is a major form for DHA in liver.
Table 6 Effects of different forms of n-3 FA on main hepatic FA composition
Group C16:0 C16:1n-6 C18:0 C18:1n-9 C18:2n-6 C20:4n-6 C22:6n-3
LF-Control 21.8 ± 0.3a 1.75 ± 0.16ab 13.3 ± 1.0a 20.1 ± 1.9 a 12.5 ± 2.0a 11.7 ± 1.3a 8.5 ± 0.3a
LF-TG 24.0 ± 0.2b 2.08 ± 0.17b 13.5 ± 0.3a 18.5 ± 1.3ab 9.0 ± 0.2b 7.72 ± 0.12b 12.7 ± 0.4bd
LF-FFA 24.0 ± 0.2b 1.77 ± 0.21ab 14.1 ± 0.8a 19.6 ± 1.6ab 10.1 ± 0.4ab 7.27 ± 0.20b 11.3 ± 0.4c
LF-EE 23.2 ± 1.0ab 1.40 ± 0.21a 14.0 ± 1.2a 15.8 ± 1.3bc 12.1 ± 0.5a 8.71 ± 0.56b 11.8 ± 0.4bc
LF-PL 25.1 ± 0.4b 1.66 ± 0.29ab 14.6 ± 1.1a 13.9 ± 1.1c 12.9 ± 0.5a 8.06 ± 0.24b 13.7 ± 0.2d
HF-Control 22.6 ± 0.4e 0.81 ± 0.07e 13.7 ± 0.5e 15.7 ± 1.1e 16.0 ± 1.4e 12.2 ± 0.7e 7.9 ± 0.2 e
HF-TG 23.2 ± 0.8ef 0.74 ± 0.19e 13.7 ± 1.1e 13.8 ± 1.3e 16.3 ± 1.1e 8.14 ± 0.52f 11.9 ± 0.4f
HF-FFA 24.0 ± 0.9ef 0.86 ± 0.21e 13.7 ± 1.1e 14.9 ± 1.7e 16.1 ± 0.9e 8.31 ± 0.43f 11.4 ± 0.7f
HF-EE 24.6 ± 0.4f 0.97 ± 0.07e 11.9 ± 0.2e 16.4 ± 0.8e 17.5 ± 0.5e 8.05 ± 0.19f 10.8 ± 0.5f
HF-PL 24.7 ± 0.8f 0.95 ± 0.08e 13.7 ± 0.9e 14.6 ± 0.9e 17.5 ± 0.9e 7.78 ± 0.52f 12.1 ± 0.2f
a–d At low fat level, means in one column sharing the same superscript letter are not significantly different determined by Duncan Multiple (P> 0.05)
e–f At high fat level, means in one column sharing the same superscript letter are not significantly different determined by Duncan Multiple (P> 0.05)
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DHA supplement (1.5%) in the low-fat diet (6%) for
4 weeks to assess the effects of molecular form on distri-
bution of omega-3 into organs. In the present study,
short-term effect of low dosage of DHA+EPA (0.7%) on
fatty acid composition in liver and brain of mice were
investigated in high fat or low fat content. The ingestion
of all the four forms of omega-3 s significantly increased
hepatic DHA content. Furthermore, we found total fat
content in diets a key factor in influencing the effect of dif-
ferent forms of omega-3 s on hepatic DHA concentration.
When low dosage of DHA was fed to mice in low fat con-
text, the effect of DHA-PL was more effective than TG,
EE and FFA forms in increasing hepatic DHA contents.
Recent studies have shown possible therapeutic and
preventive effects of cerebral DHA on many psychiatric
diseases such as attention deficit hyperactivity disorder
[32,33], depression [34], Alzheimer’s [35], and, probably
Parkinson’s disease [36]. In the present study, cerebral
DHA concentration of mice fed diets with low fat was
found to have no significant change after 1 week feeding.Table 7 Effects of different forms of n-3 fatty acid on main ce
Group C14:0 C16:0 C18:0
LF-Control 3.2 ± 0.8ab 25.0 ± 3.6a 27.9 ± 4.1ab
LF-TG 2.6±0.6b 23.4±3.6a 30.1±3.2a
LF-FFA 3.4±0.5a 26.9±2.5a 25.5±1.3b
LF-EE 2.8 ± 0.3ab 25.8 ± 2.0a 26.0 ± 0.6ab
LF-PL 2.8±0.4ab 25.0±3.4a 28.2±3.5ab
HF-Control 2.5±0.5c 25.4±0.9c 25.9±0.9c
HF-TG 2.7 ± 0.3c 23.7 ± 3.0c 29.2 ± 5.4c
HF-FFA 2.6 ± 0.3c 23.0 ± 3.0c 28.3 ± 3.3c
HF-EE 2.5±0.7c 23.9±2.3c 26.7±2.6c
HF-PL 2.3±0.5c 22.7±2.6c 27.5±2.8c
a–b At low fat level, means in one column sharing the same superscript letter are n
c–d At high fat level, means in one column sharing the same superscript letter areHowever, cerebral DHA concentration increased signifi-
cantly in mice fed diets with FFA, EE and PL at high fat
by 9.1%, 9.1% and 11.0% respectively. There was no sig-
nificant increase for cerebral DHA level in HF-TG group
but with a 5.5% higher level compared to HF-control
group. Results of this study suggested that in short-term
feeding of omega-3 s, the increase of DHA level is much
more significant in liver than in brain, and also, indi-
cated that the efficiency of dietary DHA supplement on
cerebral DHA content would be affected dramatically by
co-ingested fat content, which implied a dietary sugges-
tion when consuming omega-3 s. A series of behavioral
experiment [37-40] have shown that DHA intake could
particularly increase cerebral DHA level, and as a conse-
quence, improve learning and memory abilities of rats or
mice. Most of those studies are carried out with a long
period feeding of DHA. Our present study indicated that
short-term feeding of omega-3 in high fat meals could
also increase cerebral DHA level.
The present results indicated that DHA-PL could in-
crease DHA concentration in liver and brain during arebral FA composition in mice
C18:1n-9 C18:2n-6 C20:4n-6 C22:6n-3
19.9 ± 1.1ab 0.53 ± 0.22a 8.2 ± 1.8a 15.2 ± 2.5a
18.5±0.4b 0.52±0.08a 8.4±1.2a 16.5±2.8a
20.6±1.4a 0.63±0.15a 8.3±0.9a 14.6±2.1a
18.8 ± 1.8b 0.6 ± 0.09a 9.0 ± 0.5a 14.9 ± 2.2a
19.0±1.2b 0.6±0.07a 8.6±0.8a 15.8±1.9a
18.8±0.6c 0.74±0.02c 10.2±1.2c 16.4±1.1c
17.6 ± 1.7c 0.81 ± 0.12cd 8.8 ± 0.8d 17.3 ± 0.5cd
17.8 ± 1.1c 0.94 ± 0.28d 9.4 ± 0.7cd 17.9 ± 1.2d
18.3±0.6c 0.78±0.08cd 9.9±0.2cd 17.9±1.1d
18.0±0.6c 0.77±0.11cd 10.4±1.2c 18.2±1.5d
ot significantly different determined by Duncan Multiple (P> 0.05)
not significantly different determined by Duncan Multiple (P> 0.05)
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http://www.lipidworld.com/content/11/1/70short period. The efficiency of PL bound omega-3 s is
more significant than EE or FFA forms in increasing DHA
concentration in tissues. This result was probably due to
the difference in absorption and distribution of different
omega-3 formulation. When dietary lipids are consumed,
they are digested mainly in intestine, where the lipids are
broken into free fatty acids and other remaining sub-
stances, such as monoglycerides, ethanol or lyso-
phosphatidylcholine and they are absorbed by enterocytes
of the intestinal wall. Afterwards those absorbed FFAs and
other substances are reassembled into triglyceride and
phospholipids. For EE form fatty acids, this is obviously a
less efficient process than direct absorption of triglycerides
[14], which may lead to a worse bioavailability of EE form
omega-3 s compared with TG form. In the present study,
the superior bioavailability of PL bound DHA was prob-
ably due to its amphiphilic character, which might influ-
ence the surface composition of fat droplets thus facilitate
the binding of hydrolyzing enzymes and hence the diges-
tion [41]. Otherwise, PL was one of the main forms for
DHA in organs, especially in brains, for which the inges-
tion of DHA-PL might increase the efficiency in short-
term incorporation of DHA into organs.
Up to date, TG and EE are two main forms of fish oil
in the market. TG is the natural form of fish oil, while
EE form of omega-3 is the most common form in indus-
trial fish oil products because of convenience in synthe-
sis and purification. However, results of the present
study suggested that DHA-PL was also a bioactive form.
Furthermore, as a natural form of fish oil, PL was much
safer compared with EE or FFA form. Additionally, it
has been reported in a 10-week oxidation study that the
stability of DHA-EE decayed 33% more rapidly than
DHA-PL [42]. Thus, PL was suggested a better form for
dietary omega-3 fatty acid.
Conclusion
The present study suggested that not only total dietary
fat content but the forms of omega-3 fatty acids contrib-
uted to the effects of Omega-3 FA on lipid metabolism
in mice. DHA-PL was effective in decreasing hepatic
and serum TC, TG levels and increasing omega-3 con-
centration in liver and brain.
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